Chong Kun Dang Pharmaceutical
185750StockKO
70,800.00 ▲ +1.43%
12 juin 2026
1
Chong Kun Dang Pharmaceutical
70,800.00 ▲ +1.43%
12 juin 2026
185750StockKO

01 / À propos

Chong Kun Dang Pharmaceutical Corp. manufactures, markets, and sells medicines in South Korea and internationally. It offers prescription drugs for anti-hypertension, anti-hyperlipidaemia, and anti-diabetics, as well as immunosuppressants; over-the-counter medicines; and consumer health products, such as insecticides and hair dye products, as well as health supplements. The company was founded in 1941 and is headquartered in Seoul, South Korea.

Arberion
Loading market data